Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Enhanced subcutaneous delivery of antibody-drug conjugates with recombinant human hyaluronidase PH20: pharmacokinetics and tolerability in minipigs.
Journal: Drug delivery and translational research
Published: March 20, 2026
Anti-Endoglin monoclonal antibody prevents the progression of liver sinusoidal endothelial inflammation and fibrosis in MASH.
Journal: Life sciences
Published: November 11, 2024
Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial.
Journal: Communications medicine
Published: February 22, 2023
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
Journal: Breast cancer research and treatment
Published: October 17, 2022
Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2022
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.
Journal: JAMA oncology
Published: March 31, 2022
Monoclonal anti-endoglin antibody TRC105 (carotuximab) prevents hypercholesterolemia and hyperglycemia-induced endothelial dysfunction in human aortic endothelial cells.
Journal: Frontiers in medicine
Published: December 30, 2021
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR).
Journal: The oncologist
Published: February 01, 2021
Identification of neuroblastoma cell lines with uncommon TAZ+/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells.
Journal: Journal for immunotherapy of cancer
Published: November 09, 2020
Therapeutic effect of TRC105 and decitabine combination in AML xenografts.
Journal: Heliyon
Published: July 30, 2020
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 13, 2019
Last Updated: 09/26/2026